KRISTOPHER OLDHAM: Open Payments
NPI 1619357787 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,274 in 102 payments from 17 companies in 2025. Trend: 2023 $976 · 2024 $320 · 2025 $2,274
Food & beverage: $2,274
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 22 | $660 |
| Alkermes, Inc. | 12 | $281 |
| Vanda Pharmaceuticals Inc. | 13 | $225 |
| ABBVIE INC. | 12 | $185 |
| Otsuka America Pharmaceutical, Inc. | 8 | $173 |
| Neurocrine BioSciences, Inc. | 5 | $156 |
| Corium, LLC | 9 | $155 |
| Lundbeck LLC | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
Products named: Auvelity, REXULTI, LYBALVI, VRAYLAR, FANAPT, INGREZZA, Azstarys, ARISTADA.
Industry payments across FL — which companies pay providers there.
